๐
Emtricitabine/Tenofovir disoproxil Krka d.d.
emtricitabine;tenofovir disoproxil
HIV Infections
โ
Authorised
Generic
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Emtricitabine/Tenofovir disoproxil Krka d.d. is indicated in antiretroviral combination therapy for the treatment of HIV-1 infected adults. Emtricitabine/Tenofovir disoproxil Krka d.d. is also indicated for the treatment of HIV-1 infected adolescents, with NRTI resistance or toxicities precluding the use of first line agents, aged 12 to < 18 years.
โ ๏ธ Patient safety
No